pelvic exenteration

Summary

Summary: Removal of all of the organs and adjacent structures of the pelvis. It is usually performed to surgically remove cancer involving the bladder, uterine cervix, or rectum. (Stedman, 25th ed)

Top Publications

  1. ncbi Quality of life after pelvic exenteration
    E J Roos
    Gynecologic Oncology Center, University Medical Center Utrecht, 3508 CA Utrecht, The Netherlands
    Gynecol Oncol 93:610-4. 2004
  2. ncbi Pelvic exenteration of gynecologic malignancy: indications, and technical and reconstructive considerations
    Nicholas C Lambrou
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Jackson Memorial Hospital, Sylvester Comprehensive Cancer Center, University of Miami, FL 33136, USA
    Surg Oncol Clin N Am 14:289-300. 2005
  3. pmc Major complications following exenteration in cases of pelvic malignancy: a 10-year experience
    Dariusz Wydra
    Department of Gynecology of Medical University of Gdansk, 80 402 Gdansk ul Kliniczna 1 A, Poland
    World J Gastroenterol 12:1115-9. 2006
  4. ncbi Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma
    Christopher J Gannon
    Department of Surgical Oncology, Unit 444, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
    Ann Surg Oncol 14:1870-7. 2007
  5. ncbi Robotic-assisted laparoscopic anterior pelvic exenteration in patients with advanced ovarian cancer: Farghaly's technique
    S A Farghaly
    The Medical College of Cornell University, New York, NY, USA
    Eur J Gynaecol Oncol 31:361-3. 2010
  6. ncbi Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003)
    Gary L Goldberg
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA
    Gynecol Oncol 101:261-8. 2006
  7. ncbi Current developments for pelvic exenteration in gynecologic oncology
    Achim Schneider
    Department of Gynecology and Gynecologic Oncology, Campus Benjamin Franklin and Campus Mitte Charité, Germany
    Curr Opin Obstet Gynecol 21:4-9. 2009
  8. ncbi Primary pelvic exenteration in cervical cancer patients
    Laszlo Ungar
    Gynecologic Oncology Department, Hungarian National Cancer Institute, Hungary
    Gynecol Oncol 111:S9-12. 2008
  9. ncbi Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? a twenty-year experience
    Matias Jurado
    Department of Gynecology, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain
    Gynecol Oncol 116:38-43. 2010
  10. ncbi Follow-up of double-barreled wet colostomy after pelvic exenteration at a single institution
    Thomas Golda
    Department of Surgery, Colorectal Unit, Bellvitge University Hospital, University of Barcelona, Barcelona, Spain
    Dis Colon Rectum 53:822-9. 2010

Detail Information

Publications223 found, 100 shown here

  1. ncbi Quality of life after pelvic exenteration
    E J Roos
    Gynecologic Oncology Center, University Medical Center Utrecht, 3508 CA Utrecht, The Netherlands
    Gynecol Oncol 93:610-4. 2004
    b>Pelvic exenteration, for gynecological and urological cancer, is an extensive and mutilating procedure. The 5-year survival rate is fairly good (40-60%), but little is known about the long-term quality of life.
  2. ncbi Pelvic exenteration of gynecologic malignancy: indications, and technical and reconstructive considerations
    Nicholas C Lambrou
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Jackson Memorial Hospital, Sylvester Comprehensive Cancer Center, University of Miami, FL 33136, USA
    Surg Oncol Clin N Am 14:289-300. 2005
  3. pmc Major complications following exenteration in cases of pelvic malignancy: a 10-year experience
    Dariusz Wydra
    Department of Gynecology of Medical University of Gdansk, 80 402 Gdansk ul Kliniczna 1 A, Poland
    World J Gastroenterol 12:1115-9. 2006
    ..To analyze the major complications after exenteration of gynecological and rectal malignancies...
  4. ncbi Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma
    Christopher J Gannon
    Department of Surgical Oncology, Unit 444, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
    Ann Surg Oncol 14:1870-7. 2007
    ..To assist in patient selection for radical surgery, we sought to determine clinicopathologic factors influencing recurrence and disease-free survival (DFS) of LARC...
  5. ncbi Robotic-assisted laparoscopic anterior pelvic exenteration in patients with advanced ovarian cancer: Farghaly's technique
    S A Farghaly
    The Medical College of Cornell University, New York, NY, USA
    Eur J Gynaecol Oncol 31:361-3. 2010
    The safety and efficacy of the robotic-assisted laparoscopic approach to anterior pelvic exenteration is evaluated in patients with advanced ovarian cancer undergoing anterior pelvic exenteration for involvement of the urinary bladder ..
  6. ncbi Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003)
    Gary L Goldberg
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA
    Gynecol Oncol 101:261-8. 2006
    ..To review the trends, modifications and results of 103 consecutive total pelvic exenterations (TPE) performed at the Montefiore Medical Center and Albert Einstein College of Medicine from 1987 to 2003...
  7. ncbi Current developments for pelvic exenteration in gynecologic oncology
    Achim Schneider
    Department of Gynecology and Gynecologic Oncology, Campus Benjamin Franklin and Campus Mitte Charité, Germany
    Curr Opin Obstet Gynecol 21:4-9. 2009
    The present review aims to update new techniques of pelvic exenteration including minimal invasive surgery, and discuss other aspects of this radical surgery, including worldwide differences.
  8. ncbi Primary pelvic exenteration in cervical cancer patients
    Laszlo Ungar
    Gynecologic Oncology Department, Hungarian National Cancer Institute, Hungary
    Gynecol Oncol 111:S9-12. 2008
    ....
  9. ncbi Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? a twenty-year experience
    Matias Jurado
    Department of Gynecology, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain
    Gynecol Oncol 116:38-43. 2010
    ....
  10. ncbi Follow-up of double-barreled wet colostomy after pelvic exenteration at a single institution
    Thomas Golda
    Department of Surgery, Colorectal Unit, Bellvitge University Hospital, University of Barcelona, Barcelona, Spain
    Dis Colon Rectum 53:822-9. 2010
    ..consists of simultaneous urinary and fecal diversions into a lateral colostomy and is indicated after pelvic exenteration or in palliative operations, when complete intestinal and urinary reconstruction is not possible...
  11. ncbi Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: time to change back?
    Floor J Backes
    Division of Gynecologic Oncology, Ohio State University College of Medicine, Columbus, OH 43210, USA
    Gynecol Oncol 128:60-4. 2013
    To assess complications associated with double-barreled wet colostomy (DBWC) in the first six months after pelvic exenteration as compared to separate urinary and fecal diversion (SUD).
  12. ncbi Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer
    Ashish M Kamat
    Department of Urology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Urol 170:1868-71. 2003
    ..We describe a group of patients who had intractable perineal pain due to locally recurrent prostate cancer and underwent total pelvic exenteration for palliation.
  13. ncbi Clinical, MRI, and PET-CT criteria used by surgeons to determine suitability for pelvic exenteration surgery for recurrent rectal cancers: a Delphi study
    Min Hoe Chew
    Department of Colorectal Surgery, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
    Dis Colon Rectum 56:717-25. 2013
    Surgical resection with clear margins is the major predictor of long-term survival in recurrent rectal cancer. The extent of pelvic exenteration surgery depends on many factors including clinical and radiological criteria.
  14. ncbi Vaginal reconstruction at the time of pelvic exenteration: a surgical and psychosexual analysis of techniques
    Ramin Mirhashemi
    Division of Gynecologic Oncology, School of Medicine, University of Miami, 1475 NW 12th Avenue, Suite 3500, Miami, FL 33136, USA
    Gynecol Oncol 87:39-45. 2002
    Vaginal reconstruction following pelvic exenteration is an important aspect of the physical and psychological rehabilitation of women after radical surgery for pelvic malignancies...
  15. ncbi The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: Analysis of risk factors predicting recurrence and survival
    Jeong Yeol Park
    Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Korea
    J Surg Oncol 96:560-8. 2007
    b>Pelvic exenteration offers the last chance of cure for some advanced or recurrent gynecologic malignancy patients. The aim of this prospective study was to analyze factors associated with recurrence and survival after pelvic exenteration.
  16. ncbi Laparoscopic pelvic exenteration for gynaecological malignancy: is there any advantage?
    A Martinez
    Department of Surgical Oncology, Claudius Regaud Comprehensive Cancer Center, Toulouse, France
    Gynecol Oncol 120:374-9. 2011
    b>Pelvic exenteration (PE) remains one of the most mutilating surgical procedures with important postoperative morbidity. Laparoscopic approach has emerged in an attempt to reduce postoperative complications...
  17. ncbi Pedicle myocutaneous flaps for reconstruction following total pelvic exenteration of intrapelvic recurrent rectal cancer: report of a case
    H Ando
    Department of Surgery II, Nagoya University School of Medicine, Japan
    Surg Today 31:363-6. 2001
    ..mass of recurrent rectal carcinoma in the intrapelvic organs is commonly considered unsuitable for total pelvic exenteration (TPE); first, because it is unlikely that it would improve the prognosis and health-related quality of life ..
  18. ncbi Development and evolution of pelvic exenteration: historical notes
    M J Lopez
    Department of Surgery, St Elizabeth s Medical Center of Boston, Boston, Massachusetts 02135 2997, USA
    Semin Surg Oncol 17:147-51. 1999
    Fifty years after the development of pelvic exenteration, the operation remains a gold standard in the surgical management of advanced pelvic malignancy...
  19. ncbi [Microsurgical reconstruction of the pelvic floor after pelvic exenteration. Reduced morbidity and improved quality of life by an interdisciplinary concept]
    N M Stechl
    Klinik für Plastische, Wiederherstellungs und Handchirurgie, Markus Krankenhaus, Wilhelm Epstein Straße 4, Frankfurt am Main, Germany
    Chirurg 82:625-30. 2011
    b>Pelvic exenteration for advanced or recurrent rectal cancer often results in complex defects associated with high complication rates and morbidity for the patients...
  20. ncbi Prognostic factors in pelvic exenteration for gynecological malignancies
    G Baiocchi
    Department of Gynecologic Oncology, AC Camargo Cancer Hospital, Sao Paulo, Brazil
    Eur J Surg Oncol 38:948-54. 2012
    Analyze morbidity, mortality and prognostic factors after pelvic exenteration (PE) for gynecological malignancies.
  21. ncbi Pelvic exenteration and reconstruction
    Emery M Salom
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Miami School of Medicine, Jackson Memorial Hospital Sylvester Comprehensive Cancer Center, Miami, Florida, USA
    Cancer J 9:415-24. 2003
    ..Most of the advancements have been focused on the reconstructive phase after pelvic exenteration. A few select patients can be free of any external appliances such as a colostomy bag with utilization of a ..
  22. ncbi Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies
    Susannah M Mourton
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, MRI 1026, New York, NY 10021, USA
    Gynecol Oncol 100:533-6. 2006
    To determine the incidence and prognostic implications of positive mesorectal lymph nodes in patients undergoing total pelvic exenteration for recurrent gynecologic malignancies.
  23. ncbi Reconstruction of the pelvic floor with human acellular dermal matrix and omental flap following anterior pelvic exenteration
    Adeyiza O Momoh
    Department of Plastic Surgery, Unit 443, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Plast Reconstr Aesthet Surg 63:2185-7. 2010
    Pelvic floor reconstruction after pelvic exenteration is challenging, particularly with bacterial contamination and/or pelvic irradiation...
  24. ncbi Laparoscopic hand-assisted Miami Pouch following laparoscopic anterior pelvic exenteration
    C Pomel
    Department of Surgical Oncology, Gustave Roussy Institute Comprehensive Cancer Centre, Villejuif 94805, France
    Gynecol Oncol 93:543-5. 2004
    To determine the feasibility of a laparoscopic hand-assisted Miami Pouch following a laparoscopic anterior pelvic exenteration.
  25. ncbi Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies
    Christina Fotopoulou
    Department of Gynecology and Obstetrics, Charite, Campus Virchow Clinic, University Hospital, Berlin, Germany
    J Surg Oncol 101:507-12. 2010
    We evaluated the outcome of pelvic exenteration in women with locally advanced primary or recurrent gynecological malignancies.
  26. ncbi Pelvic exenteration with curative intent for recurrent uterine malignancies
    Fady Khoury-Collado
    Department of Surgery, Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Gynecol Oncol 124:42-7. 2012
    To evaluate the outcomes observed with pelvic exenteration with curative intent for recurrent uterine malignancies in the modern era.
  27. ncbi Total pelvic exenteration for primary local advanced colorectal cancer
    H S Chen
    Department of Colon and Rectal Surgery, Chang Gung Memorial Hospital at Kaohsiung, College of Medicine, Chang Gung University, Kaohsiung Hsien, Taiwan, Republic of China
    World J Surg 25:1546-9. 2001
    Total pelvic exenteration (TPE) is an ultraradical operative procedure for locally advanced pelvic tumors with high morbidity and mortality rates...
  28. ncbi Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute
    S Sharma
    Division of Gynecologic Oncology, Department of Surgery, Roswell Park Cancer Institute, Buffalo, New York 14263, USA
    Int J Gynecol Cancer 15:475-82. 2005
    ..Charts of 48 women who underwent a pelvic exenteration between January 1980 and December 1999 were reviewed, and several outcomes were analyzed...
  29. ncbi Surgical management of advanced and recurrent cervical cancer
    R Estape
    University of Miami, Division of Gynecologic Oncology, Florida, USA
    Semin Surg Oncol 16:236-41. 1999
    ..Current data associated with these procedures for advanced or recurrent cervical cancer are described...
  30. ncbi Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis
    Yoshihiro Moriya
    Department of Surgery, National Cancer Center Hospital, Tokyo, Japan
    Dis Colon Rectum 47:2047-53; discussion 2053-4. 2004
    This study evaluates the effectiveness of total pelvic exenteration with distal sacrectomy for fixed recurrent tumor that developed from primary rectal cancer.
  31. ncbi Pelvic exenteration and sphincter preservation in the treatment of soft tissue sarcomas
    A Lopes
    Pelvic Surgery Department, Centro de Tratamento e Pesquisa Hospital do Cancer A C Camargo, Rua Professor Antonio Prudente, 211, Liberdade, 01509 010 Sao Paulo, SP, Brazil
    Eur J Surg Oncol 30:972-5. 2004
    ..A complete resection is considered the main factor associated to a good prognosis, which justifies the employment of a pelvic exenteration (PE) in selected cases.
  32. ncbi Pelvic exenteration in gynecologic oncology: a single institution study over 20 years
    T Benn
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine, USA
    Gynecol Oncol 122:14-8. 2011
    The profile of women with gynecologic malignancies treated with pelvic exenteration has changed since the initial description of this procedure. We sought to evaluate our experience with pelvic exenteration over the last 20 years.
  33. ncbi Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan
    Angelo Maggioni
    Division of Gynecologic Oncology, European Institute of Oncology, Via Ripamonti 435 20141, Milan, Italy
    Gynecol Oncol 114:64-8. 2009
    Analyze morbidity and survival after pelvic exenteration (PE) of gynecological malignancies.
  34. ncbi Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients
    G Houvenaeghel
    Department of Surgery, Institut Paoli Calmettes, 13009 Marseille, France
    Gynecol Oncol 92:680-3. 2004
    The objective of this study was to analyze the postoperative outcome of patients undergoing urinary diversion at the time of pelvic exenteration.
  35. ncbi Laparoscopic total pelvic exenteration for cervical cancer relapse
    C Pomel
    Department of Surgical Oncology, Gustave Roussy Institute Comprehensive Cancer Centre, 39, rue Camille Desmoulins, 94805, Villejuif, France
    Gynecol Oncol 91:616-8. 2003
    Laparoscopy classically reduces morbidity and invasiveness. To decrease the operative morbidity associated with exenteration, we considered the possibility of performing a total pelvic exenteration by the laparoscopic approach.
  36. ncbi Management of advanced pelvic cancer by exenteration
    D M Kecmanovic
    Department for Colorectal Surgery, Clinical Center of Serbia, First Surgical University Hospital, Koste Todorovica 6, 11000 Belgrade, Serbia and Montenegro, Yugoslavia
    Eur J Surg Oncol 29:743-6. 2003
    ..To describe our results in managing locally advanced primary or recurrent pelvic malignancies...
  37. ncbi Pelvic exenteration as treatment of recurrent or advanced gynecologic and urologic cancer
    E J Roos
    Gynecological Oncological Center, University Medical Center Utrecht, Utrecht, The Netherlands
    Int J Gynecol Cancer 15:624-9. 2005
    b>Pelvic exenteration is used as therapeutic option for advanced or recurrent cancer in the pelvis. We determined the complications of and the survival after pelvic exenteration...
  38. ncbi Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases
    Shailesh Puntambekar
    Galaxy Laparoscopy Institute, 25 A, Karve Road, Near Garware College, Pune 411 004, India
    Gynecol Oncol 102:513-6. 2006
    ..The aim of this study was to retrospectively evaluate, in a series of 16 consecutive patients, the technique, feasibility and oncological safety of laparoscopic anterior exenteration for locally advanced pelvic cancers...
  39. pmc Total pelvic exenteration for primary and recurrent malignancies
    F T J Ferenschild
    Department of Surgical Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    World J Surg 33:1502-8. 2009
    ..Total pelvic exenteration (TPE) is an exenterative operation for these advanced tumors and involves en bloc resection of the rectum, ..
  40. ncbi Pelvic exenteration for advanced pelvic malignancies
    Timothy M Pawlik
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Unit 444, P O Box 301402, Houston, Texas, 77230 1402, USA
    Ann Surg Oncol 13:612-23. 2006
  41. ncbi Pelvic exenteration for primary and recurrent gynaecological malignancies
    Johannes H W de Wilt
    Department of Surgical Oncology, Erasmus MC Daniel den Hoed Cancer Center, P O Box 5201, 3008 AE Rotterdam, The Netherlands
    Eur J Obstet Gynecol Reprod Biol 134:243-8. 2007
    Analyse the outcome of pelvic exenteration for gynaecological malignancies in a tertiary referral center. Post-operative in-hospital morbidity, long-term morbidity, disease free and overall survival rates were studied.
  42. ncbi Pelvic exenteration for gynaecological tumours: achievements and unanswered questions
    Michael Hockel
    Department of Obstetrics and Gynaecology, University of Leipzig, Philipp Rosenthal Str 55, 04103 Leipzig, Germany
    Lancet Oncol 7:837-47. 2006
    b>Pelvic exenteration has been used for 60 years to treat cancers of the lower and middle female genital tract in radiated pelves...
  43. ncbi A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration
    Amreen Husain
    Stanford University School of Medicine, Div of Gynecologic Oncology and Memorial Sloan Kettering Cancer Center, USA
    Gynecol Oncol 106:177-80. 2007
    To determine the accuracy of (18)FDG PET in identifying sites of metastatic disease prior to pelvic exenteration or radical resection in patients (pts) with recurrent cervical or vaginal cancers.
  44. ncbi Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement
    Kirk K S Austin
    Department of Colorectal Surgery and Surgical Outcome Research Centre, Royal Prince Alfred Hospital and Discipline of Surgery, University of Sydney, Sydney, Australia
    Dis Colon Rectum 52:1223-33. 2009
    ..The aim of this study was to outline our surgical approach to lateral pelvic sidewall involvement and assess the oncologic and long-term outcomes...
  45. ncbi Modified posterior pelvic exenteration for ovarian cancer
    Gilles Houvenaeghel
    Service de Chirurgie Oncologique 2, Institut Paoli Calmettes, Marseille, France
    Int J Gynecol Cancer 19:968-73. 2009
    A modified posterior pelvic exenteration (MPE) might be needed to reach an optimal tumoral reduction. The issue of this study is to relate a multicentric experience of this kind of resection.
  46. ncbi [Laparoscopy-assisted vaginal pelvic exenteration]
    G Ferron
    Département de chirurgie cancérologique, Institut Claudius Regaud, 20 24, rue du Pont Saint Pierre, 31052 Toulouse, France
    Gynecol Obstet Fertil 34:1131-6. 2006
    The aim of the study was to evaluate the feasibility, morbidity and survival outcome of laparoscopy-assisted vaginal pelvic exenteration.
  47. ncbi Posterior pelvic exenteration for primary rectal cancer
    G C Bannura
    Department of Colorectal Surgery, Hospital Clinico San Borja Arriaran, Santiago, Chile
    Colorectal Dis 8:309-13. 2006
    Indications for and the prognosis of posterior pelvic exenteration (PPE) in rectal cancer patients are not clearly defined...
  48. ncbi Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer
    Kazutaka Yamada
    First Department of Surgery, Kagoshima University School of Medicine, Kagoshima, Japan
    Dis Colon Rectum 45:1078-84. 2002
    ..in patients with locally advanced primary or recurrent rectal cancer would be an extended resection such as pelvic exenteration and sacral resection...
  49. ncbi Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period
    Seiji Ishiguro
    Colorectal Surgery Division, National Cancer Center Hospital, Tokyo, Japan
    Surgery 145:189-95. 2009
    Patients with stage T4 rectal cancer are known to have poor survival and often require pelvic exenteration (PE). We describe the oncologic outcome of PE for patients with clinical T4 rectal cancer over a 30-year period.
  50. ncbi Total pelvic exenteration: results from a multispecialty team approach to complex cancer surgery
    Y H Ho
    Department of Colorectal Surgery, Singapore General Hospital, Singapore
    Int Surg 86:107-11. 2001
    Total pelvic exenteration is often the only curative option for recurrent or locally advanced pelvic cancers, but it carries a high risk of mortality and morbidity...
  51. ncbi Outcome of total pelvic exenteration for primary rectal cancer
    Hideyuki Ike
    Second Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, 4 57 Urafune cho, Minami Ku, Yokohama 232 0024, Japan
    Dis Colon Rectum 46:474-80. 2003
    ..location, tumor stage, lymph node metastasis, histologic differentiation, and adjuvant therapies) that are useful in predicting long-term survival in patients undergoing total pelvic exenteration for advanced primary rectal cancer.
  52. ncbi Outcomes of colorectal anastomoses during pelvic exenteration for gynaecological malignancy
    S W Lim
    Centre for Colorectal Cancer, Research Institute and Hospital, National Cancer Centre, Goyang, Korea
    Br J Surg 95:770-3. 2008
    Although pelvic exenteration is frequently indicated during surgery for gynaecological malignancy, performing a colorectal anastomosis remains contentious because of concern about leakage...
  53. ncbi Quality of life of survivors after pelvic exenteration for rectal cancer
    Kirk K S Austin
    Department of Colorectal Surgery, University of Sydney, Sydney, New South Wales, Australia
    Dis Colon Rectum 53:1121-6. 2010
    There is little information about the impact of pelvic exenteration on patients' quality of life. This study aimed to measure quality of life for longer-term disease-free survivors after pelvic exenteration.
  54. ncbi Robot-assisted laparoscopic anterior pelvic exenteration for bladder cancer in the female patient
    Raj S Pruthi
    Division of Urologic Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    J Endourol 22:2397-402; discussion 2402. 2008
    ..Herein, we describe our approach and initial experience with robotic-assisted laparoscopic anterior pelvic exenteration in the female patient with bladder cancer.
  55. ncbi Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA
    Jonathan S Berek
    Division of Gynecologic Oncology, David Geffen School of Medicine, University of California Los Angeles, UCLA Center for the Health Sciences 24 127, 10833 LeConte Avenue, Los Angeles, CA 90095 1740, USA
    Gynecol Oncol 99:153-9. 2005
    To retrospectively assess the outcome of patients undergoing pelvic exenteration for recurrent or persistence gynecologic malignancy and the clinical features associated with outcome and survival.
  56. ncbi Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra
    G Dalbagni
    Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    J Urol 166:1759-61. 2001
    ..August 1996 and July 1999, 6 women were treated for locally advanced carcinoma of the urethra with anterior pelvic exenteration followed by high dose 192iridium intraoperative radiation therapy...
  57. ncbi Long-term follow-up of continent urinary diversion after pelvic exenteration for gynecologic malignancies
    Gilles Karsenty
    Assistance Publique Hopitaux de Marseille, Hopital Salvator, Urology Department, Marseille, France Université de la Méditerranée, Faculte de Medecine, Marseille, France
    Gynecol Oncol 97:524-8. 2005
    The objective of this retrospective study was to analyze the long-term outcome of patients undergoing a continent urinary diversion (UD) at the time of pelvic exenteration (PE).
  58. ncbi Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer
    Ramon E Jimenez
    Division of Colorectal Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Dis Colon Rectum 46:1619-25. 2003
    Total pelvic exenteration is performed infrequently in selected patients with locally advanced or recurrent colorectal cancer...
  59. ncbi Explorative laparoscopy prior to exenterative surgery
    Christhardt Köhler
    Department of Gynecology, Friedrich Schiller University, Bachstrasse 18, 07740 Jena, Germany
    Gynecol Oncol 86:311-5. 2002
    ..The objective of this study was to identify the advantages and limits of laparoscopy for assessment of eligibility for exenterative procedures in patients with gynecologic malignancies...
  60. ncbi [Total pelvic exenteration in the treatment of advanced pelvic cancer]
    G Mitulescu
    Centrul de Chirurgie Generală şi Transplant Hepatic, Institutul Clinic Fundeni, Bucuresti
    Chirurgia (Bucur) 102:143-54. 2007
    Total pelvic exenteration (TPE) is a radical and aggressive procedure performed in the local advanced pelvic cancer started from any pelvic organ...
  61. ncbi Transposed right colon segment for vaginal reconstruction after pelvic exenteration
    V Bridoux
    Department of Digestive Surgery, Rouen University Hospital, France
    Eur J Surg Oncol 36:1080-4. 2010
    Vaginal reconstruction following pelvic exenteration surgery for malignant disease is an important step in the physical and psychological rehabilitation of such patients...
  62. ncbi Outcome of total pelvic exenteration for locally recurrent rectal cancer
    Hideyuki Ike
    Second Department of Surgery, Yokohama City University, Yokohama, Japan
    Hepatogastroenterology 50:700-3. 2003
    ..However treatment of choice remains controversial. We assessed the results of total pelvic exenteration for locally recurrent cancer of the rectum retrospectively.
  63. ncbi Pelvic exenteration in the age of modern chemoradiation
    Kate A McLean
    Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA, USA
    Gynecol Oncol 121:131-4. 2011
    To examine outcomes after pelvic exenteration in women treated with modern chemoradiation and surgical techniques.
  64. ncbi Pelvic exenteration for advanced and recurrent malignancy
    Evita Zoucas
    Department of Surgery, University of Lund, Lund, Sweden
    World J Surg 34:2177-84. 2010
    ..Improved surgical techniques and oncological treatment render many advanced pelvic tumors amenable to curative resection. We evaluated morbidity, survival, and quality of life (QoL) after extended pelvic procedures...
  65. ncbi Laparoscopy-assisted vaginal pelvic exenteration
    Gwenael Ferron
    Department of Surgical Oncology, Institut Claudius Regaud Cancer Center, 20 24, rue du Pont St Pierre, 31052 Toulouse Cedex, France
    Gynecol Oncol 100:551-5. 2006
    The aim of this study was to evaluate the feasibility, morbidity and survival outcome of laparoscopy-assisted vaginal pelvic exenteration.
  66. ncbi Vaginal reconstruction following supra-levator total pelvic exenteration
    Mark A Rettenmaier
    Gynecologic Oncology Associates, Hoag Cancer Center, 351 Hospital Road, Suite 507, Newport Beach, CA 92663, USA
    Gynecol Oncol 102:397-9. 2006
    ..vault and prolapse repair systems are innovative and minimally invasive procedures that may prove to be effective in controlling the levator defect and reconstructing the vagina in patients undergoing supra-levator pelvic exenteration.
  67. ncbi Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer
    M Vermaas
    Department of Surgical Oncology, Erasmus MC Daniel den Hoed Cancer Center, P O Box 5201, 3008 AE Rotterdam, The Netherlands
    Eur J Surg Oncol 33:452-8. 2007
    To report the role of total pelvic exenteration in a series of locally advanced and recurrent rectal cancers.
  68. ncbi Evolution of pelvic exenteration
    Marvin J Lopez
    Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, USA
    Surg Oncol Clin N Am 14:587-606, vii. 2005
  69. ncbi Palliative pelvic exenteration for patients with gynecological malignancies
    Gustavo Cardoso Guimaraes
    Department of Pelvic Surgery, A C Camargo Cancer Hospital, Rua Prof Antonio Prudente, 211, Liberdade, Sao Paulo, SP 01509 010, Brazil
    Arch Gynecol Obstet 283:1107-12. 2011
    To evaluate the results of palliative pelvic exenteration in patients with gynecologic tumors.
  70. ncbi Composite pelvic exenteration: is it worthwhile?
    Marvin J Lopez
    Department of Surgery, Division of Surgical Oncology, St Elizabeth s Medical Center and Tufts University School of Medicine, Boston, MA 02135, USA
    Ann Surg Oncol 11:27-33. 2004
    ..Few data exist regarding the futility or utility of pelvic exenteration with en bloc resection of involved portions of the bony pelvis.
  71. ncbi The use of tissue flaps as an adjunct to pelvic surgery
    Susan Galandiuk
    Department of Surgery, Section of Colon and Rectal Surgery, University of Louisville School of Medicine, and Digestive Health Center, University of Louisville Hospital, Louisville, KY 40292, USA
    Am J Surg 190:186-90. 2005
    ..The use of autologous muscle and myocutaneous flaps has been applied to the management and prevention of these clinical problems and found to be most helpful...
  72. ncbi [Results of resection of locally recurrent rectal cancer]
    C Billiet
    Departement de Chirurgie, Hotel Dieu, 69288 Lyon Cedex 02, France
    Ann Chir 131:601-7. 2006
    ....
  73. ncbi The role of pelvic exenteration for treatment of pelvic malignancy--a nine-year experience
    D Wydra
    Department of Gynecology, Medical University of Gdansk, Poland
    Eur J Gynaecol Oncol 26:418-22. 2005
    b>Pelvic exenteration offers the last chance for some women with gynecological and rectal malignancy...
  74. ncbi Double-barreled wet colostomy is a safe option for simultaneous urinary and fecal diversion. Analysis of 56 procedures from a single institution
    Gustavo C Guimaraes
    Departamento de Cirurgia Pélvica, Hospital do Cancer A C Camargo, Rua Professor Antonio Prudente, Sao Paulo, Brazil
    J Surg Oncol 93:206-11. 2006
    ..Wide pelvic tumors need urinary and fecal diversion. We set out to assess the efficacy of the double-barreled wet colostomy (DBWC) in patients undergoing simultaneous double diversion...
  75. ncbi Pelvic exenteration without external urinary or fecal diversion in gynecological cancer patients
    L Ungar
    Department of Obstetrics, Gynecology and Gynecologic Oncology, St Stephen Hospital, Nagyvárad Tér 1, Budapest 1091, Hungary
    Int J Gynecol Cancer 16:364-8. 2006
    ..Our present experience demonstrated that anterior and total supralevator pelvic exenteration in patients with gynecological malignancies is feasible with orthotopic reconstruction of the lower urinary ..
  76. ncbi [Reconstruction with skin flaps of the posterior aspect of the thighs after total pelvic evisceration with removal of vulvo-perineal soft tissues in recurrent vulvar squamous carcinoma]
    M Rinaldi
    Dipartimento di Emergenza e Trapianti d Organo, Sezione di Chirurgia Generale e Trapianto di Fegato, Universita di Bari
    Suppl Tumori 4:S208. 2005
    ..After two years of follow up, the patient is alive without evidence of disease...
  77. ncbi Ureteral stenting via an ileal conduit using a gastroscope
    Simon D S Woods
    Monash University Department of Surgery at Cabrini Hospital, St Frances Xavier Cabrini Hospital, Malvern, Victoria, Australia
    J Urol 168:185. 2002
    ..We describe a technique that facilitates retrograde ureteral cannulation and stenting in patients with an ileal conduit...
  78. ncbi Qualitative assessment of patient experiences related to extended pelvic resection for rectal cancer
    F C Wright
    Division of Surgical Oncology, Sunnybrook and Women s College Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
    J Surg Oncol 93:92-9. 2006
    ..While there is potential for cure in a subset of patients, the cost in terms of morbidity can be high. Few descriptions of the physical, psychological, social, and emotional experiences of these patients exist...
  79. ncbi Total pelvic exenteration: the reconstructive phase
    Gary L Goldberg
    Albert Einstein College of Medicine, Montefiore Medical Center, Department of OB GYN and Women s Health, 1825 Eastchester Road, Room 722, Bronx, NY 10461, USA
    Gynecol Oncol 99:S149. 2005
  80. ncbi Prostatic carcinosarcoma 15 years after combined external beam radiation and brachytherapy for prostatic adenocarcinoma: a case report
    T Y Tseng
    Division of Urologic Surgery and Duke Prostate Center, Duke University Medical Center, Durham, NC 27704, USA
    Prostate Cancer Prostatic Dis 9:195-7. 2006
    ..beam radiation therapy (EBRT) and brachytherapy for prostatic adenocarcinoma 15 years prior underwent total pelvic exenteration for presumed rectal sarcoma with prostatic invasion. Pathology revealed carcinosarcoma of prostatic origin...
  81. ncbi Treatment strategy for locally recurrent rectal cancer
    Yoshihiro Moriya
    Colorectal Surgery Division, National Cancer Center Hospital, Chuo Ku, Tokyo 104 0045, Japan
    Jpn J Clin Oncol 36:127-31. 2006
    ..A staging system using degree of fixation and other prognostic factors should be developed so that appropriate treatment modalities are applied to each case...
  82. ncbi Is en-bloc resection of locally recurrent rectal carcinoma involving the urinary tract indicated?
    Luca Stocchi
    Department of Colorectal Surgery, A30, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA
    Ann Surg Oncol 13:740-4. 2006
    ..This study investigated morbidity, mortality, and long-term survival after multimodality management of locally recurrent rectal carcinoma involving the urinary tract...
  83. ncbi Indications for primary and secondary exenterations in patients with cervical cancer
    Simone Marnitz
    Department of Radiooncology, Charite Universitatsmedizin, Berlin, Germany
    Gynecol Oncol 103:1023-30. 2006
    ..In addition, the term "palliative exenteration" is not precisely defined. We evaluate the role of primary exenteration in patients with stage IVA cervical cancer and the role of secondary palliative exenteration...
  84. ncbi Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer
    Yoshihiro Moriya
    Department of Surgery, National Cancer Center Hospital, Chuo Ku, Tokyo, Japan
    Surg Oncol Clin N Am 14:225-38. 2005
  85. ncbi Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer
    Dan Leibovici
    Department of Urology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Prostate 62:101-4. 2005
    ..the accuracy of transrectal ultrasound (TRUS) versus magnetic resonance imaging (MRI) in the detection of rectal wall involvement by prostate cancer in patients undergoing salvage total pelvic exenteration (TPE) or cystoprostatectomy.
  86. ncbi Aggressive surgical treatment for patients with T4 rectal cancer
    Y Moriya
    Colorectal Surgical Unit, National Cancer Centre Hospital, Tsukiji 5 1 1, Chuo Ku, Tokyo 104 0045, Japan
    Colorectal Dis 5:427-31. 2003
    ..To investigate the outcome of surgical treatment for patients with T4 rectal cancer and to evaluate prognostic factors influencing 5-year disease-free survival...
  87. ncbi Pelvic exenteration and sphincter preservation: an analysis of 96 cases
    Antonio Henrique Oliveira Poletto
    Pelvic Surgery Department, Centro de Tratamento e Pesquisa, Hospital do Cancer, A C Camargo Sao Paulo, SP, Brazil
    J Surg Oncol 86:122-7. 2004
    b>Pelvic exenteration (PE) is characterized by its technical complexity and morbidity rate...
  88. ncbi The oblique rectus abdominal myocutaneous flap for complex pelvic wound reconstruction
    Daniel E Abbott
    Department of Surgery, Northwestern University, Feinberg School of Medicine, 201 E Huron, Chicago, Illinois 60611, USA
    Dis Colon Rectum 51:1237-41. 2008
    ..Here we detail the oblique rectus abdominal myocutaneous flap in achieving closure of complex perineal wounds...
  89. ncbi [Interdisciplinary aspects of surgery of the pelvis minor and retroperitoneum]
    R Ackermann
    Klinik für Urologie der Heinrich Heine Universität Düsseldorf
    Chirurg 75:379-89. 2004
    ..Because of the growing number of long-term survivors, preservation of quality of life becomes more and more important...
  90. ncbi [Posterior pelvic exenteration in locoregional recurrence of rectal carcinoma--indications, technique and outcome]
    T Lehnert
    Sektion Onkologische Chirurgie,
    Chirurg 72:1393-401. 2001
    ..the indication, preoperative diagnostic and therapeutic procedures as well as results of the posterior pelvic exenteration with sacral resection...
  91. ncbi The role of pelvic exenteration in the management of recurrent rectal cancer
    James T Kakuda
    City of Hope National Medical Center, Department of General Oncologic Surgery, Duarte, CA 91010, USA
    Am J Surg 186:660-4. 2003
    ..Use of extirpative surgery in the setting of recurrent rectal cancer is controversial given the poor overall outcome of such patients and the morbidity associated with exenteration...
  92. ncbi [Vaginal reconstruction after pelvic exenteration: when and which techniques?]
    Gwenael Ferron
    Departement de Chirurgie, CRLC, Institut Claudius Regaud, Toulouse
    Bull Cancer 90:435-40. 2003
    ..Gracilis and gluteal thight flaps are particularly adapted in pelvectomy with perineal resection. Enteroclpoplasty and omental flap must be used in radical colpectomie or difficulty pelvic access...
  93. ncbi How to treat the persistent perineal sinus after rectal excision
    John H Pemberton
    Division of Colon and Rectal Surgery, Mayo Clinic and Mayo Foundation, East 6 A 200 First Street SW, Rochester, MN 55905, USA
    Colorectal Dis 5:486-9. 2003
    ..We examined these methodologies in terms of indications, technical details, complications and outcomes. Finally, the newest techniques for eliminating persistent perineal sinus tracts are detailed...
  94. ncbi Rectus abdominis myocutaneous and myoperitoneal flaps for neovaginal reconstruction after radical pelvic surgery: comparison of flap-related morbidity
    John T Soper
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Box 3079, Durham, NC 27710, USA
    Gynecol Oncol 97:596-601. 2005
    ..To compare flap-specific complications of rectus abdominis myocutaneous (RAM) and myoperitoneal (RAMP) flap neovagina reconstructions performed concurrently with radical pelvic procedures...
  95. ncbi [Surgical treatment of recurrent locoregional rectal cancer]
    Laurent Ghouti
    Service de Chirurgie Digestive et Oncologique, Hopital Purpan, Toulouse
    Gastroenterol Clin Biol 31:55-67. 2007
    ..After curative surgery, 5-year global survival is between 30% and 40%. Palliative resection of macroscopic residues is not recommended. Careful patient selection for curative surgery is the best way to optimize treatment in these cases...
  96. ncbi Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer
    Johan N Wiig
    Department of Surgical Oncology, The Norwegian Radium Hospital, Oslo, Norway
    Eur J Surg 168:42-8. 2002
    To study the complication rate, local recurrence rate, and survival after total pelvic exenteration for primary advanced and recurrent rectal cancer.
  97. ncbi Abdominal sacral resection for posterior pelvic recurrence of rectal carcinoma: analyses of prognostic factors and recurrence patterns
    Takayuki Akasu
    Colorectal Surgery Division, National Cancer Center Hospital, 5 1 1, Tsukiji, Chuo Ku, Tokyo, 104 0045, Japan
    Ann Surg Oncol 14:74-83. 2007
    ..The purpose of this study was to evaluate the results of ASR for posterior pelvic recurrence of rectal carcinoma and to analyze prognostic factors and recurrence patterns...
  98. ncbi [Pelvic exenteration in the treatment of locally advanced tumors of surgical, gynaecological and urological origin]
    F Antos
    Department of Surgery, Institute for Postgraduate Medical Education and Department of Urology, University Hospital Bulovka, Prague
    Zentralbl Chir 126:777-9. 2001
    b>Pelvic exenteration is a radical extirpative procedure designed to treat pelvic malignancy that has invaded more than one of the hollow organs of the gastrointestinal or genitourinary tracts...
  99. ncbi Clinical aspects and prognosis of pelvic recurrence of cervical carcinoma
    T Kasamatsu
    Division of Gynecology, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, Tokyo 104 0045, Japan
    Int J Gynaecol Obstet 89:39-44. 2005
    ..To identify which patients with locally recurrent cervical carcinoma are potentially curable...
  100. ncbi Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers
    M C Fleisch
    Universitaets Frauenklinik, Heinrich Heine Universitaet, Duesseldorf, Germany
    J Surg Oncol 95:476-84. 2007
    We wanted to identify factors which allow predicting long-term survival after pelvic exenteration (PE) for locally advanced or recurrent gynecologic malignancies.
  101. ncbi [Pelvic exenterations for gynaecological cancer--a 10 year institutional review]
    Sueli Pinelo
    Serviço de Ginecologia, Instituto Portugues de Oncologia, Porto
    Acta Med Port 19:99-104. 2006
    b>Pelvic exenteration consists in a radical surgical procedure for patients with advanced cancer but limited to central pelvis...

Research Grants6

  1. Minicomputer Upgrade for the Clinical Resarch Database
    Colin Begg; Fiscal Year: 2002
    ..This proposal is a request for funds to upgrade the hardware platform once again to maintain the performance of the system in the face of these rapidly increasing demands. ..
  2. A Method for Validating Gene - Disease Associations
    Colin Begg; Fiscal Year: 2004
    ..abstract_text> ..
  3. Epidemiologic Parameters of Rare Cancer Risk Factors
    Colin Begg; Fiscal Year: 2005
    ..All of these aims are motivated by an international study of the genetic epidemiology of melanoma that is currently in progress. ..
  4. Evaluating Expectations for Breast Reconstruction
    Andrea Pusic; Fiscal Year: 2008
    ..unreadable] [unreadable] [unreadable]..
  5. Tumor metastasis: Biobehavioral mechanisms
    Anil K Sood; Fiscal Year: 2009
    ....
  6. Statistical Methods for Identifying Clonal Tumors
    Colin B Begg; Fiscal Year: 2011
    ....